Video

Dr. Backes on Pelvic Exenteration Surgery in Gynecologic Cancer

Floor J. Backes, MD, associate professor at The Ohio State University Comprehensive Cancer Center, discusses pelvic exenteration surgery for patients with gynecologic cancer.

Floor J. Backes, MD, associate professor at The Ohio State University Comprehensive Cancer Center, discusses pelvic exenteration surgery for patients with gynecologic cancer.

Pelvic exeneration is a rare procedure, explains Backes, as only 150 are done in the United States each year. This procedure removes all of the pelvic organs, which can cause a high-risk of complications and distant recurrence.

Some potential risk factors for recurrence include positive lymph nodes, lymphovascular invasion, perineural invasion, and tumor size. There are several studies suggesting that tumors greater than 3 cm increase the risk of a local and distant recurrence, and can decrease survival chances.

With this rare type of surgery, it is important to consult and counsel patients, according to Backes. Patients can undergo pelvic reconstruction after surgery.

Related Videos
J. Bradley Elder, MD
Rimas V. Lukas, MD
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center
Kathleen N. Moore, MD, MS
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine